1. Home
  2. AXNX vs ZI Comparison

AXNX vs ZI Comparison

Compare AXNX & ZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXNX
  • ZI
  • Stock Information
  • Founded
  • AXNX 2012
  • ZI 2007
  • Country
  • AXNX United States
  • ZI United States
  • Employees
  • AXNX N/A
  • ZI N/A
  • Industry
  • AXNX Medical/Dental Instruments
  • ZI Computer Software: Prepackaged Software
  • Sector
  • AXNX Health Care
  • ZI Technology
  • Exchange
  • AXNX Nasdaq
  • ZI Nasdaq
  • Market Cap
  • AXNX 3.5B
  • ZI 3.6B
  • IPO Year
  • AXNX N/A
  • ZI 2020
  • Fundamental
  • Price
  • AXNX $69.63
  • ZI $9.90
  • Analyst Decision
  • AXNX Hold
  • ZI Hold
  • Analyst Count
  • AXNX 9
  • ZI 21
  • Target Price
  • AXNX $70.67
  • ZI $13.71
  • AVG Volume (30 Days)
  • AXNX 340.6K
  • ZI 6.0M
  • Earning Date
  • AXNX 10-28-2024
  • ZI 10-28-2024
  • Dividend Yield
  • AXNX N/A
  • ZI N/A
  • EPS Growth
  • AXNX N/A
  • ZI N/A
  • EPS
  • AXNX N/A
  • ZI 0.04
  • Revenue
  • AXNX $408,809,000.00
  • ZI $1,231,800,000.00
  • Revenue This Year
  • AXNX $25.48
  • ZI N/A
  • Revenue Next Year
  • AXNX $19.56
  • ZI $1.13
  • P/E Ratio
  • AXNX N/A
  • ZI $250.08
  • Revenue Growth
  • AXNX 27.81
  • ZI 2.78
  • 52 Week Low
  • AXNX $48.30
  • ZI $7.65
  • 52 Week High
  • AXNX $69.91
  • ZI $19.39
  • Technical
  • Relative Strength Index (RSI)
  • AXNX 62.61
  • ZI 45.67
  • Support Level
  • AXNX $69.10
  • ZI $9.65
  • Resistance Level
  • AXNX $69.67
  • ZI $10.72
  • Average True Range (ATR)
  • AXNX 0.34
  • ZI 0.33
  • MACD
  • AXNX 0.03
  • ZI -0.06
  • Stochastic Oscillator
  • AXNX 82.50
  • ZI 19.76

About AXNX Axonics Inc.

Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is predominantly used to treat patients with overactive bladder, fecal incontinence, and urinary retention. Geographically, the company generates majority of its revenue from United States and rest from International markets.

About ZI ZoomInfo Technologies Inc

ZoomInfo Technologies Inc provides a go-to-market intelligence platform for sales and marketing teams. Its cloud-based go-to-market data and insights platform deliver comprehensive and high-quality intelligence and analytics to provide sales and marketing professionals with accurate information and insights on the organizations and professionals. Nearly all of its revenue is derived from the United States.

Share on Social Networks: